Ritalin and Bedridden - a phase IV clinical study of FDA data
Summary:
Bedridden is reported as a side effect among people who take Ritalin (methylphenidate hydrochloride), especially for people who are female, 50-59 old, also take Ativan, and have Stress and anxiety.
The phase IV clinical study analyzes which people have Bedridden when taking Ritalin. It is created by eHealthMe based on reports of 26,179 people who have side effects when taking Ritalin from the FDA, and is updated regularly.
What is Ritalin?
Ritalin has active ingredients of methylphenidate hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 29,427 Ritalin users. Check the latest studies of Ritalin.
What is Bedridden?
Bedridden is found to be associated with 874 drugs and 1,105 conditions by eHealthMe. Check the latest studies of Bedridden.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
26,179 people reported to have side effects when taking Ritalin.
Among them, 32 people (0.12%) have Bedridden.

Among these 32 people:
What is the gender of people who have Bedridden when taking Ritalin? *
- female: 77.42 %
- male: 22.58 %
What is the age of people who have Bedridden when taking Ritalin? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 4.17 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 12.5 %
- 50-59: 50.0 %
- 60+: 33.33 %
What are other drugs people take besides Ritalin? *
- Dilaudid: 8 people, 25.00%
- Ativan: 8 people, 25.00%
- Lyrica: 7 people, 21.88%
- Levaquin: 7 people, 21.88%
- Lasix: 7 people, 21.88%
- Phenytoin: 6 people, 18.75%
- Simvastatin: 6 people, 18.75%
- Carboplatin: 6 people, 18.75%
- Lovastatin: 6 people, 18.75%
- Prilosec: 6 people, 18.75%
What are other side effects people have besides Bedridden? *
- Pain: 15 people, 46.88%
- Fatigue (feeling of tiredness): 13 people, 40.62%
- Headache (pain in head): 10 people, 31.25%
- Weakness: 9 people, 28.12%
- Bone Disorder: 9 people, 28.12%
- Intervertebral Disc Protrusion (spinal disc protrusion): 9 people, 28.12%
- Fall: 9 people, 28.12%
- Pain In Extremity: 9 people, 28.12%
- Weight Decreased: 8 people, 25.00%
- Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 7 people, 21.88%
What are the existing conditions these people have? *
- Stress And Anxiety: 9 people, 28.12%
- Pain: 8 people, 25.00%
- Hypercalcaemia Of Malignancy (elevated calcium (ca+) level in the blood with cancer): 6 people, 18.75%
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 5 people, 15.62%
- High Blood Cholesterol: 4 people, 12.50%
- Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 4 people, 12.50%
- High Blood Pressure: 4 people, 12.50%
- Indigestion: 3 people, 9.38%
- Neuropathy Peripheral (surface nerve damage): 3 people, 9.38%
- Abdominal Pain Upper: 3 people, 9.38%
* Approximation only. Some reports may have incomplete information.
Do you take Ritalin and have Bedridden?
- Check whether Bedridden is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Ritalin:
- Ritalin (29,427 reports)
Bedridden treatments and more:
- Bedridden (14,887 reports)
How severe was Bedridden and when was it recovered:
Expand to all the drugs that have ingredients of methylphenidate hydrochloride:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Ritalin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Bedridden:
- Bedridden (874 drugs)
Browse all the conditions that are associated with Bedridden:
- Bedridden (1,105 conditions)
Related publications that referenced our studies
- Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
- Yektas ?, Samurcu ND, Tufan AE, "Loss of Eyebrows (Madarosis) After Use of Long-Acting Methylphenidate: Case Report", Journal of Clinical Psychopharmacology, 2017 Aug .
- Ersoy MA, Ersoy HT, "Manic symptoms associated with isotretinoin and methylphenidate combination: a case report", Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2014 Sep .
- Coskun M, Adak I, Akaltun I, "Bilateral gynecomastia in a preadolescent boy while under treatment with methylphenidate and paroxetine", Journal of clinical psychopharmacology, 2014 Aug .
- Adak, I., & Coskun, M. , "Symptomatic cholelithiasis associated with combined use of methylphenidate and fluoxetine in an otherwise healthy adolescent girl", Psychiatry and Clinical Psychopharmacology, 2014 Jan .
- Coskun, M., & Adak, I. , "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2014 Jan .
- Yalcin O, Aslan AA, Sari BA, Turkbay T, "Possible methylphenidate related hoarseness and disturbances of voice quality: two pediatric cases", Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2012 Sep .
- Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .
- Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
- Yektas ?, Samurcu ND, Tufan AE, "Loss of Eyebrows (Madarosis) After Use of Long-Acting Methylphenidate: Case Report", Journal of Clinical Psychopharmacology, 2017 Aug .
- Ersoy MA, Ersoy HT, "Manic symptoms associated with isotretinoin and methylphenidate combination: a case report", Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2014 Sep .
- Coskun M, Adak I, Akaltun I, "Bilateral gynecomastia in a preadolescent boy while under treatment with methylphenidate and paroxetine", Journal of clinical psychopharmacology, 2014 Aug .
- Adak, I., & Coskun, M. , "Symptomatic cholelithiasis associated with combined use of methylphenidate and fluoxetine in an otherwise healthy adolescent girl", Psychiatry and Clinical Psychopharmacology, 2014 Jan .
- Coskun, M., & Adak, I. , "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2014 Jan .
- Yalcin O, Aslan AA, Sari BA, Turkbay T, "Possible methylphenidate related hoarseness and disturbances of voice quality: two pediatric cases", Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2012 Sep .
- Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on methylphenidate hydrochloride (the active ingredients of Ritalin) and Ritalin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Skelaxin cause Multiple Sclerosis? - 2 seconds ago
- Could Skelaxin cause Neck Mass? - 4 seconds ago
- Could Strattera cause Bilirubin Conjugated Increased? - 15 seconds ago
- Could Eliquis cause Abortion Spontaneous? - 20 seconds ago
- Hypotonia and drugs of ingredients of potassium chloride - 21 seconds ago
- Femoral Arterial Stenosis and drugs of ingredients of anastrozole - 25 seconds ago
- Could Levaquin cause Vitamin D Decreased? - 26 seconds ago
- Drug interactions of Prednisone and Libtayo - 28 seconds ago
- Lung Neoplasm Malignant and Dyspnea Exacerbated - 29 seconds ago
- Could Hctz cause Pelvic Fluid Collection? - 35 seconds ago